Brown Brothers Harriman & CO Haleon PLC Transaction History
Brown Brothers Harriman & CO
- $13.6 Billion
- Q4 2024
A detailed history of Brown Brothers Harriman & CO transactions in Haleon PLC stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 7,569 shares of HLN stock, worth $76,825. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,569
Previous 13,653
44.56%
Holding current value
$76,825
Previous $144,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HLN
# of Institutions
663Shares Held
432MCall Options Held
269KPut Options Held
40.6K-
Dodge & Cox San Francisco, CA179MShares$1.81 Billion1.07% of portfolio
-
Clearbridge Investments, LLC New York, NY32.8MShares$333 Million0.26% of portfolio
-
Harding Loevner LP Bridgewater, NJ24.1MShares$245 Million1.6% of portfolio
-
Wellington Management Group LLP Boston, MA15.3MShares$156 Million0.03% of portfolio
-
Morgan Stanley New York, NY9.89MShares$100 Million0.01% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $46.9B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...